183 related articles for article (PubMed ID: 7018502)
1. Comparison of the effects of colestipol hydrochloride and clofibrate on plasma lipids and lipoproteins in the treatment of hypercholesterolemia.
Seplowitz AH; Smith FR; Berns L; Eder HA; Goodman DS
Atherosclerosis; 1981 Apr; 39(1):35-43. PubMed ID: 7018502
[TBL] [Abstract][Full Text] [Related]
2. Effect of colestipol and clofibrate on plasma lipid and lipoproteins in type IIa hyperlipoproteinemia.
Hunninghake DB; Probstfield JL; Crow LO; Isaacson SO
Metabolism; 1981 Jun; 30(6):605-9. PubMed ID: 7231197
[TBL] [Abstract][Full Text] [Related]
3. Effect of colestipol and clofibrate, singly and in combination, on plasma lipid and lipoproteins in type IIb hyperlipoproteinemia.
Hunninghake DB; Bell C; Olson L
Metabolism; 1981 Jun; 30(6):610-5. PubMed ID: 7231198
[TBL] [Abstract][Full Text] [Related]
4. Effects of colestipol, clofibrate, and placebo on plasma lipoproteins of patients with hypercholesterolemia.
Crouse JR; Grundy SM
Metabolism; 1981 Feb; 30(2):123-8. PubMed ID: 7464561
[TBL] [Abstract][Full Text] [Related]
5. Effect of clofibrate and colestipol singly and in combination on plasma lipids and lipoproteins in type III hyperlipoproteinemia.
Hoogwerf BJ; Peters JR; Frantz ID; Hunninghake DB
Metabolism; 1985 Oct; 34(10):978-81. PubMed ID: 4046841
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of colestipol and clofibrate in type IIa hyperlipoproteinemia.
Vecchio TJ; Linden CV; O'Connell MJ; Heilman J
Arch Intern Med; 1982 Apr; 142(4):721-3. PubMed ID: 7073415
[TBL] [Abstract][Full Text] [Related]
7. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
Rose HG; Haft GK; Juliano J
Atherosclerosis; 1976; 23(3):413-27. PubMed ID: 178325
[TBL] [Abstract][Full Text] [Related]
8. Colestipol, clofibrate, cholestyramine and combination therapy in the treatment of familial hyperbetalipoproteinaemia.
Stein EA; Heimann KW
S Afr Med J; 1975 Jul; 49(31):1252-6. PubMed ID: 168650
[TBL] [Abstract][Full Text] [Related]
9. Long-term trial with colestipol plus clofibrate in familial hypercholesterolemia.
Fellin R; Baggio G; Briani G; Baiocchi MR; Manzato E; Baldo G; Crepaldi G
Atherosclerosis; 1978 Feb; 29(2):241-9. PubMed ID: 348207
[TBL] [Abstract][Full Text] [Related]
10. The effects of colestipol when combined with clofibrate in the treatment of severe hyperlipidemia. Short-term and long-term studies.
Lithell H; Vessby B; Boberg J; Hellsing K
Atherosclerosis; 1980 Oct; 37(2):175-86. PubMed ID: 7000089
[TBL] [Abstract][Full Text] [Related]
11. Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Witztum JL; Simmons D; Steinberg D; Beltz WF; Weinreb R; Young SG; Lester P; Kelly N; Juliano J
Circulation; 1989 Jan; 79(1):16-28. PubMed ID: 2642754
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasma lipoprotein lipids in hypercholesterolaemic patients treated with the bile acid-sequestering resin, colestipol.
Clifton-Bligh P; Miller NE; Nestel PJ
Clin Sci Mol Med; 1974 Dec; 47(6):547-57. PubMed ID: 4375013
[No Abstract] [Full Text] [Related]
13. The effects of colestipol on the metabolism of very-low-density lipoproteins in man.
Witztum JL; Schonfeld G; Weidman SW
J Lab Clin Med; 1976 Dec; 88(6):1008-18. PubMed ID: 186544
[TBL] [Abstract][Full Text] [Related]
14. Low-dose colestipol plus probucol for hypercholesterolemia.
Dujovne CA; Chernoff SB; Krehbiel P; Jackson B; DeCoursey S; Taylor H
Am J Cardiol; 1984 Jun; 53(11):1514-8. PubMed ID: 6375337
[TBL] [Abstract][Full Text] [Related]
15. Colestipol, clofibrate, and phytosterols in combined therapy of hyperlipidemia.
Grundy SM; Mok HY
J Lab Clin Med; 1977 Feb; 89(2):354-66. PubMed ID: 833472
[TBL] [Abstract][Full Text] [Related]
16. [A comparative study of colestipol and colestyramine in children and adolescents with familial hypercholesterolaemia (author's transl)].
Mordasini R; Twelsick F; Oster P; Schellenberg B; Raetzer H; Heuck CC; Schlierf G
Monatsschr Kinderheilkd (1902); 1978 Jul; 126(7):436-40. PubMed ID: 672910
[TBL] [Abstract][Full Text] [Related]
17. Probucol further lowers the serum cholesterol of colestipol-treated patients with hypercholesterolemia.
Schonfeld G; Witztum J; Basich P
Artery; 1982; 10(2):99-104. PubMed ID: 7092583
[TBL] [Abstract][Full Text] [Related]
18. The effects of colestipol hydrochloride on serum lipoprotein lipid and apolipoprotein B and A-I concentrations in children heterozygous for familial hypercholesterolemia.
Groot PH; Dijkhuis-Stoffelsma R; Grose WF; Ambagtsheer JJ; Fernandes J
Acta Paediatr Scand; 1983 Jan; 72(1):81-5. PubMed ID: 6407278
[TBL] [Abstract][Full Text] [Related]
19. Results of colestipol therapy in Type II hyperlipoproteinemia.
Lees AM; McCluskey MA; Lees RS
Atherosclerosis; 1976; 24(1-2):129-40. PubMed ID: 182181
[TBL] [Abstract][Full Text] [Related]
20. The effects of colestipol tablets compared with colestipol granules on plasma cholesterol and other lipids in moderately hypercholesterolemic patients.
Insull W; Davidson MH; Demke DM; Dujovne CA; Eckert SM; Ginsberg D; Goldberg AC; Hodis HN; Hughes TA; Kane JP
Atherosclerosis; 1995 Jan; 112(2):223-35. PubMed ID: 7772081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
